SCHEMBL31037472

SCHEMBL31037472

CC(C)(C)OC(=O)N1CCC(c2ccc(C#Cc3cc(NC(=O)Oc4ccccc4)ccc3-c3ccncc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.47
▸ JAK2 O60674 6/20 0.45
▸ JAK3 P52333 6/20 0.45
▸ PTK2 Q05397 6/20 0.45
▸ P2RY14 Q15391 1/20 0.40
▸ RET P07949 1/20 0.40
▸ GPR119 Q8TDV5 4/20 0.40
▸ WNT3A P56704 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ PTPN2 P17706 1/20 0.38
▸ PTPN1 P18031 1/20 0.38
▸ PTPN6 P29350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31744280 0.83 MAPK14 (0.46) NAMPT
SCHEMBL31037312 0.82 GPR119 (0.45) NAMPTJAK2JAK3PTK2P2RY14
SCHEMBL25567301 0.81 NAMPT (0.69) NAMPTJAK2JAK3PTK2GPR119
SCHEMBL31744301 0.78 NAMPT (0.47) NAMPTJAK2JAK3PTK2RET
SCHEMBL31037287 0.77 NAMPT (0.45) NAMPTROCK2MAPT
SCHEMBL1988842 0.75 NAMPT (0.60) NAMPTGPR119MAPTPTPN2PTPN1
SCHEMBL29537824 0.75 NAMPT (0.60) NAMPTGPR119MAPTPTPN2PTPN1
SCHEMBL1988843 0.75 NAMPT (0.60) NAMPTGPR119MAPTPTPN2PTPN1
SCHEMBL31037303 0.74 ALOX15 (0.43) NAMPTGPR119MAPT
SCHEMBL16907476 0.73 NAMPT (0.52) NAMPTJAK2JAK3PTK2P2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4663628-A1 NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Samjin Pharmaceutical Co., Ltd. (KR) 2025-12-17 — — EP disclosed
WO-2024166024-A1 NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 삼진제약주식회사 2024-08-15 — — WO disclosed
Send feedback